Radiofrekvensablation reducerer risikoen ved dysplastisk Barrett oesophagus

    1 Citationer (Scopus)

    Abstrakt

    Barrett's esophagus (BE) with dysplasia is generally accepted as the precursor to oesophageal cancer. Thus, methods to eradicate BE and dysplasia have been evaluated. Recently, radiofrequency ablation (RFA) has shown promising results with few adverse effects. The studies concerning RFA are, however, small and heterogeneous. Only six studies have included more than 100 patients and only one is a prospective randomized trial. The purpose of this article is to describe the treatment of BE and especially the indications and challenges of RFA, including complications, buried glands and recurrence.

    Bidragets oversatte titelRadiofrequency ablation reduces the risk in Barrett's oesophagus with dysplasia.
    OriginalsprogDansk
    TidsskriftUgeskrift for læger [online]
    Vol/bind176
    Udgave nummer2A
    ISSN1603-6824
    StatusUdgivet - 6 jan. 2014

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Radiofrekvensablation reducerer risikoen ved dysplastisk Barrett oesophagus'. Sammen danner de et unikt fingeraftryk.

    Citationsformater